Projects  /  Case Study

Mapping Medicaid’s “medically frail” exemption, state by state.

How a summer on Vertex Pharmaceuticals’ US Public Affairs team turned a new federal Medicaid rule into a 50-state tracker, an executive briefing, and a plain-language guide for patients.

Role
US Public Affairs Intern, Policy & Reimbursement
Timeline
May – Jul 2026
Patient groups
Cystic fibrosis, sickle cell disease, kidney disease
Deliverables
50-state tracker · executive briefing · patient one-pager

A federal rule, applied fifty different ways.

The One Big Beautiful Bill Act, signed in July 2025, created Medicaid work requirements for certain adults ages 19–64 enrolled in expansion coverage, and most states must implement them by January 1, 2027. Roughly 20 million people could be subject to the new reporting rules, and the Congressional Budget Office estimates that 5.2–7.5 million enrollees could lose coverage.

People with serious or complex medical conditions can be exempt as “medically frail” — but states have discretion over how they define and apply that exemption, and a diagnosis alone may not qualify someone. For patients with cystic fibrosis, sickle cell disease, and kidney disease, the state they live in could shape whether they keep their coverage.

Track it, brief it, translate it.

  1. Track

    Built and maintained a 50-state tracker of “medically frail” exemption definitions under the new requirements, giving Public Affairs one place to compare how each state was defining and applying the exemption.

  2. Brief

    Synthesized the CMS interim final rule into an executive briefing for ~40 US Public Affairs staff, including Director- and VP-level leadership.

  3. Translate

    Wrote a patient-facing one-pager that turns eligibility rules, required actions, and enforcement deadlines into plain language for cystic fibrosis, sickle cell, and kidney disease advocacy organizations — backed by six primary federal sources.

Used by the team, shared with patients.

50states tracked, adopted by Public Affairs to flag where CF and sickle cell coverage was most at risk
~40staff briefed, including Director- and VP-level leadership
6primary federal sources behind the patient one-pager
~500state bills tracked across the wider policy portfolio

The patient one-pager was cleared by Vertex for public sharing. The tracker and executive briefing are internal to Vertex and are not published here.

Policy & Regulatory Analysis State Policy Tracking Executive Briefing Plain-Language Writing Patient Advocacy Research Synthesis